Article Type
Review
Published
This paper provides an updated narrative review on the pathophysiology, manifestations and management approaches for common hyperinflammatory syndromes.
Review
This paper provides an updated narrative review on the pathophysiology, manifestations and management approaches for common hyperinflammatory syndromes.
Original Research
This study evaluated the safety and efficacy of azoximer bromide when used in combination with standard of care treatment in patients hospitalized with COVID-19.
Case Report
We present four clinical reports that illustrate the clinical uses of GMA with the medical device Adacolumn® in patients with different backgrounds and immune-mediated inflammatory arthritis.
Review
Corrigendum
The authors wish to make the following corrections to their article: Efimov SV, Matsiyeuskaya NV, Boytsova OV, et al. Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study. Drugs in Context 2021; 10: 2021-11-1. DOI: 10.7573/dic.2020-11-1